Apogee Therapeutics · San Francisco, United StatesApogee Therapeutics
Fundamentalsi
Latest valuationNot disclosed
Credibility rating
Revenue / run rateNot disclosed
StageStartup profile
Latest roundSeries B · $149M
Total funding$169M
Team sizeTeam size not disclosed
LocationSan Francisco, United States
IndustryStartup
Source records1
Ownership data
Cap table not disclosed
Apogee Therapeutics does not include shareholding history in the normalized startup source files.
Financial performance
All FinancialsSource snapshot
REVENUE (USD)Not disclosed Not disclosed
FUNDING (USD)$169M Series B · $149M
Insufficient history
Historical revenue and profit series are not present in the source files for this private company.
REVENUE GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
PROFIT GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
About
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients' needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.
This profile is normalized from the startup source files. Exact historical financials are shown only when present in the dataset.
Sources
Angel Investors and Venture Capital (1)
InvestorTypeSignal
Founder / employee ownershipBootstrappedNot disclosed in source records
Similar companies
See moreCompanyStartup metricSignal rangeValuationCategory
Altos LabsAL$3B$3B roundLHNot disclosedValuationStartupStartup
Enavate SciencesES$300M$300M roundLHNot disclosedValuationStartupStartup
Nightpeak EnergyNE$200M$200M roundLHNot disclosedValuationStartupStartup